BioTechniques News
Maddy Chapman
This edition of the biotech bi-weekly highlights the datasets revolutionizing our understanding of the human genome, new technologies for conducting multiplex immunofluorescence and metabolomics, and partnerships facilitating the integration of AI and antibody discovery.
Products
A fully automated multiplex immunofluorescence system
MGI Tech (Shenzhen, China), a company committed to developing core tools and technologies that drive innovation in life science, has announced the European launch of VisiOmics, a fully automated multiplex immunofluorescence staining and imaging system, at this year’s European Congress of Pathology, held in Stockholm (Sweden) from 12–16 September.
Unveiling a metabolomics kit for the lab
Metabolon (NC, USA), a company providing metabolomics solutions to advance a wide variety of life science research, diagnostic, therapeutic development and precision medicine applications, has announced that the Metabolon Verus™ Metabolomics Profiling Kit is now available to order, moving Metabolon’s first metabolomics kit from early access into full commercial availability.
First announced in May 2026 at the 74th ASMS Conference on Mass Spectrometry (CA, USA), the Metabolon Verus™ Metabolomics Profiling Kit is designed to extend Metabolon’s capabilities beyond centralized services and into laboratories worldwide, combining sample preparation, quality control, automated compound annotation and access to Metabolon’s Integrated Bioinformatics Platform in a single standardized workflow.
The launch of a new microplate reader
Thermo Fisher Scientific (MA, USA) has announced the launch of the Thermo Scientific™ Multiskan™ Ease Absorbance Microplate Reader, designed to support protein quantification, enzyme-linked immunosorbent assays (ELISAs), cell viability studies, microbial growth monitoring and other routine laboratory applications with simplified operation and dependable performance.
We spoke to the authors of this recent paper about their new protocol and top tips for putting it into practice.
Partnerships
Where antibodies meet AI
Sapio Sciences (MD, USA), the AI lab informatics company, has announced that FairJourney Bio (Porto, Portugal), an antibody discovery company, has selected the Sapio Scientific AI Platform, including Sapio’s LIMS, ELN and AI co-scientist solutions to replace spreadsheet-based records and manual reporting processes across its international operations.
Searching the human genome database
Google DeepMind‘s (London, UK) new AlphaGenome Atlas provides scientists with a comprehensive, searchable resource designed to accelerate understanding of the human genome.
Stowers Institute for Medical Research (MO, USA) investigator Julia Zeitlinger has partnered with the Google DeepMind team led by Vice President of Science and Chief Scientist Žiga Avsec to map and interpret the patterns in DNA that regulate biological processes inside cells. At the same time, additional scientific collaborators from leading institutions across the United States and England helped test how the new resource could be used to identify impactful genetic variation in humans.
Bioprocessing training for biopharma
Sartorius (Göttingen, Germany) and the National Institute for Bioprocessing Research and Training (Dublin, Ireland) are partnering to establish the world’s most comprehensive training center for intensified and fully continuous bioprocessing in Dublin. Starting in the fourth quarter of 2026, the center will serve as a hub for practical training and knowledge sharing to help the biopharmaceutical industry adopt intensified, digitalized and continuous manufacturing processes.
AI & Antibodies miniseries | Designing smart antibodies in the age of AI
Andrew Buchanan, Senior Vice President of Discovery at a biotech company currently in stealth mode, and former Principle Scientist at AstraZeneca, on his paper: How to think about designing smart antibodies in the age of GenAI: integrating biology, technology and experience.
Funding, datasets and awards
Funding for rapid molecular testing
Fuse Diagnostics (Cambridge, UK), a developer of next-generation molecular diagnostics for point-of-need testing, has announced it has raised £1 million to accelerate commercialization of its proprietary Flip™ product platform and expand manufacturing capabilities at its headquarters in Cambridge. The investment will support Fuse’s ambition to make gold-standard molecular diagnostics, currently limited to use in specialist laboratories, accessible in environments where rapid testing is needed most.
AI antibody design challenge
Zymo Research (CA, USA), a biotechnology and protein engineering company, demonstrated top-tier performance in the AIntibody Design Challenge, an international benchmark of AI-driven antibody discovery inspired by the Critical Assessment of Structure Prediction. In the affinity maturation challenge, Zymo Research’s computational protein engineering platform ranked among the top four teams, generating antibody variants with substantially improved binding affinity.
From health to disease: creating the largest human multi-omics database
Mayo Clinic (MN, USA) has announced the launch of Precure, LLC, with founding partner Thermo Fisher Scientific, the world leader in serving science, to help transform how the life sciences community understands the biological changes that occur as people move from health toward disease.
Precure, LLC will create one of the world’s leading biomedical datasets through one of the largest human multi-omics data-generation efforts, integrating proteomic, genomic and longitudinal clinical data to help researchers identify early biological signals of disease and provide a foundation for new discoveries in disease biology, diagnostics and therapeutics.
This article is a collection of rehosted press releases, each linked above. Material may have been edited for length and house style. For further information, please contact the cited source. Our press release publishing policy can be accessed here.
The post The biotech bi-weekly: new multiplex immunofluorescence tool, a human genome database and funding for rapid molecular testing appeared first on BioTechniques.
Powered by WPeMatico